Diligence memo · auto-generated · as of July 2, 2026
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
CollPlant Biotechnologies Ltd operates in Biotech / Pharma, based in REHOVOT.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
CollPlant Biotechnologies Ltd has raised $18M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.5M on 2020-03-02.
Most recent recorded round closed around 2026-02-04.
Valuation (modeled)modeled
Provath models CollPlant Biotechnologies Ltd at approximately $9.9M (range $4.5M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.58× the median modeled value of Series A Biotech / Pharma companies in 2025–2027 (16 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 25 months.
Last raise 5 mo ago; this sector typically re-raises about every 15 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 74% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 33% of those peers.
Closest niche peers: Evio Pharmacy Solutions, LLC, Ruby Bio, Inc., Intelligent Bio Solutions Inc., Barnwell Bio, Inc., Arkea Bio Corp..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.